Steve E. Krognes, CFO and Treasurer at Denali Therapeutics Inc. (DNLI), sold 1,296 shares at $37.09 ($48K) on 2022-02-09, disclosed to the SEC on 2022-02-11.
Open-market sale of $48k DNLI by CFO and Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| DNLI | SELL | 2025-01-08 | $139K | — | Filing → |
| DNLI | SELL | 2025-01-03 | $608K | — | Filing → |
| DNLI | SELL | 2024-10-02 | $871K | — | Filing → |